Calabresi P - Search Results

1

Alpha-synuclein in Parkinson's disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction.

Calabresi P, Mechelli A, Natale G, Volpicelli-Daley L, Di Lazzaro G, Ghiglieri V. Calabresi P, et al. Cell Death Dis. 2023 Mar 1;14(3):176. doi: 10.1038/s41419-023-05672-9. Cell Death Dis. 2023. PMID: 36859484 Free PMC article. Review.

2

Plastic and behavioral abnormalities in experimental Huntington's disease: a crucial role for cholinergic interneurons.

Picconi B, Passino E, Sgobio C, Bonsi P, Barone I, Ghiglieri V, Pisani A, Bernardi G, Ammassari-Teule M, Calabresi P. Picconi B, et al. Among authors: calabresi p. Neurobiol Dis. 2006 Apr;22(1):143-52. doi: 10.1016/j.nbd.2005.10.009. Epub 2005 Dec 2. Neurobiol Dis. 2006. PMID: 16326108

3

A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia.

Gardoni F, Picconi B, Ghiglieri V, Polli F, Bagetta V, Bernardi G, Cattabeni F, Di Luca M, Calabresi P. Gardoni F, et al. Among authors: calabresi p. J Neurosci. 2006 Mar 15;26(11):2914-22. doi: 10.1523/JNEUROSCI.5326-05.2006. J Neurosci. 2006. PMID: 16540568 Free PMC article.

4

Plastic abnormalities in experimental Huntington's disease.

Di Filippo M, Tozzi A, Picconi B, Ghiglieri V, Calabresi P. Di Filippo M, et al. Among authors: calabresi p. Curr Opin Pharmacol. 2007 Feb;7(1):106-11. doi: 10.1016/j.coph.2006.08.010. Epub 2006 Oct 30. Curr Opin Pharmacol. 2007. PMID: 17071137 Review.

5

l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation.

Picconi B, Paillé V, Ghiglieri V, Bagetta V, Barone I, Lindgren HS, Bernardi G, Angela Cenci M, Calabresi P. Picconi B, et al. Among authors: calabresi p. Neurobiol Dis. 2008 Feb;29(2):327-35. doi: 10.1016/j.nbd.2007.10.001. Epub 2007 Oct 11. Neurobiol Dis. 2008. PMID: 17997101

6

Neuronal networks and synaptic plasticity in Parkinson's disease: beyond motor deficits.

Calabresi P, Galletti F, Saggese E, Ghiglieri V, Picconi B. Calabresi P, et al. Parkinsonism Relat Disord. 2007;13 Suppl 3:S259-62. doi: 10.1016/S1353-8020(08)70013-0. Parkinsonism Relat Disord. 2007. PMID: 18267247 Review.

7

Striatal synaptic changes in experimental parkinsonism: role of NMDA receptor trafficking in PSD.

Picconi B, Ghiglieri V, Bagetta V, Barone I, Sgobio C, Calabresi P. Picconi B, et al. Among authors: calabresi p. Parkinsonism Relat Disord. 2008;14 Suppl 2:S145-9. doi: 10.1016/j.parkreldis.2008.04.019. Epub 2008 Jun 25. Parkinsonism Relat Disord. 2008. PMID: 18583173 Review.

8

Acetyl-L-Carnitine selectively prevents post-ischemic LTP via a possible action on mitochondrial energy metabolism.

Bagetta V, Barone I, Ghiglieri V, Di Filippo M, Sgobio C, Bernardi G, Calabresi P, Picconi B. Bagetta V, et al. Among authors: calabresi p. Neuropharmacology. 2008 Aug;55(2):223-9. doi: 10.1016/j.neuropharm.2008.05.015. Epub 2008 May 24. Neuropharmacology. 2008. PMID: 18590920

9

Molecular mechanisms underlying levodopa-induced dyskinesia.

Calabresi P, Di Filippo M, Ghiglieri V, Picconi B. Calabresi P, et al. Mov Disord. 2008;23 Suppl 3:S570-9. doi: 10.1002/mds.22019. Mov Disord. 2008. PMID: 18781674 Review.

10

The endocannabinoid system in Parkinson's disease.

Di Filippo M, Picconi B, Tozzi A, Ghiglieri V, Rossi A, Calabresi P. Di Filippo M, et al. Among authors: calabresi p. Curr Pharm Des. 2008;14(23):2337-47. doi: 10.2174/138161208785740072. Curr Pharm Des. 2008. PMID: 18781984 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,391 results

Search Page

Filters